Report
Christophe-Raphaël Ganet

Bastide : Résultats S1 2023/24 - Résilience de l’activité dans un contexte encore inflationniste

>Un ROC S1 légèrement en dessous de nos attentes - Bastide publie ses résultats S1 2023/24 et affiche un EBITDA de 53,6 M€, +7.5% (marge : 20,2% vs. 20% au S1 2022/23). Le ROC se situe à 21,9 M€ (+2,1%) et le RN à 2,4 M€ (-7,7%), impacté par 1/ une augmentation de 150 pb des frais de personnels, 2/ une perte nette de 1,2 M€ liée à un abandon d’activité (cession de Livramedom) 3/ des coûts de restructuration de 0,4 M€, 4/ une augmentation des frais financiers pour 11,9...
Underlying
Bastide Le Confort Medical SA

Bastide le Confort Medical is a holding company. Through its subsidiaries, Co. is engaged in the home health care industry. Co. retails and rents medical equipment and provides medical services. Products include breathing apparatus, orthopedic shoes, walking aids and wheelchairs, home appliances and furniture adapted to the needs of the lesser able, with the recent addition of equipment related to perfusion and nutrition. Co. operates through a number of outlets concentrated mainly in the South of France, offering advice and information to customers along with the provision and maintenance of medical equipment.

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Analysts
Christophe-Raphaël Ganet

Other Reports on these Companies
Other Reports from Oddo BHF

ResearchPool Subscriptions

Get the most out of your insights

Get in touch